AI Science Tracker

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

2 discoveries from 2026

Discoveries

LLM-based virtual screening identifies two NIR-II fluorophores tested in vitro and in vivo

Researchers trained a large-language-model framework to predict fluorophore emission wavelengths and used virtual screening to prioritize NIR-II imaging molecules. Two candidates were experimentally characterized and showed favorable imaging performance in vitro and in vivo, according to the abstract. The abstract supplies no quantitative imaging effect sizes. This summary is limited to the abstract and October 15, 2026 publication metadata; the candidates are imaging probes.

Technology: Large language model for structure-property prediction, with virtual screening

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Two computationally prioritized fluorescent candidates characterized for imaging in vitro and in vivo.
  • Still unknown: Source checking does not establish independent confirmation. Review date: 2026-11-15.
  • AI role: A large language model predicted emission wavelengths and guided virtual screening to choose candidates.

Evidence sources: https://onlinelibrary.wiley.com/doi/10.1002/smll.76251?af=R

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

BioGDR predicts cell-line sensitivity to an ALDH1B1 inhibitor

BioGDR combines molecular structure with learned, predicted gene-expression and kinase-effect features and transcriptomic cell representations. Prospective in-vitro tests confirmed differential sensitivity to Golgicide A-2, including T84 colorectal cells (reported IC50 1.09 μM). This is a cell-line sensitivity result, not evidence of clinical benefit or discovery of the compound itself.

Technology: BioGDR multimodal interpretable deep learning; pathway graph attention

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The primary source reports the study-specific result summarized here.
  • Still unknown: Independent replication and clinical benefit are not established by this source review.
  • AI role: The model integrates predicted compound effects and cell transcriptomes to rank drug responses; the study prospectively tests candidate sensitivity in cell lines.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13396495/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: Primary source text reviewed; source_checks specify accessible sections..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.